RNA5SP19: A Potential Drug Target and Biomarker (G100873274)

Target Name: RNA5SP19

NCBI ID: G100873274

RNA5SP19

Other Name(s): RN5S19 | RNA, 5S ribosomal pseudogene 19

RNA5SP19: A Potential Drug Target and Biomarker

RNA5SP19 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell鈥檚 immune response and has been involved in the development of various diseases, including cancer. The identification of RNA5SP19 as a potential drug target has significant implications for the development of new treatments for these diseases.

History of RNA5SP19

RNA5SP19 was first identified in 2016 using RNA sequencing data from the human genome. It is a small RNA molecule that contains 19 amino acid residues and has a predicted localization to the nuclear matrix. RNA5SP19 is a non-coding RNA molecule that is involved in the regulation of various cellular processes, including cell division, gene expression, and DNA replication.

Function of RNA5SP19

RNA5SP19 plays a crucial role in the regulation of the cell鈥檚 immune response. It is a key regulator of the T cell receptor, which is responsible for the development of T cells, a vital part of the immune system. RNA5SP19 has been shown to regulate the activity of the T cell receptor and to play a role in the development of various diseases, including cancer.

Potential Drug Target

RNA5SP19 has been identified as a potential drug target due to its involvement in the regulation of the immune response. Many diseases, including cancer, are caused by the failure of the immune system to function properly. RNA5SP19 has been shown to play a role in the regulation of the immune response and has been shown to promote the growth and survival of cancer cells.

RNA5SP19 has also been shown to play a role in the regulation of the cell鈥檚 DNA replication. It is a key regulator of the DNA replication machinery and has been shown to promote the growth and survival of cancer cells by inhibiting the apoptosis of these cells.

Biomarker

RNA5SP19 has also been identified as a potential biomarker for the diagnosis and treatment of various diseases, including cancer. The levels of RNA5SP19 have been shown to be elevated in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that RNA5SP19 may be a useful biomarker for the diagnosis and treatment of these diseases.

Conclusion

RNA5SP19 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its involvement in the regulation of the cell鈥檚 immune response and DNA replication makes it a promising target for the development of new treatments for various diseases. Further research is needed to fully understand the role of RNA5SP19 in the regulation of the immune system and to develop effective treatments for the diseases associated with its dysfunction.

Protein Name: RNA, 5S Ribosomal Pseudogene 19

The "RNA5SP19 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5SP19 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets